We suggest that this early cardiac hypertrophy might be related to an excess of ROS production by NADPH oxidase—an enzyme implicated in LVH [22]- based on the observed elevation of cardiac p22phox expression in MUN males. Here, FMO5 is linked to cardiac hypertrophy.